P+P advises Equistone on the acquisition of United Initiators
Equistone Partners Europe (“Equistone”) has acquired a majority stake in the United Initiators group. The sellers were the private equity investors Vision Capital and Speyside Equity. The transaction is still subject to approval by the competent antitrust authorities.
Headquartered in Pullach, Germany, United Initiators is one of the largest global chemical producers, primarily of organic peroxides and persulfates. The company has a century of history and employs approximately 600 workers. It operates seven production facilities in Europe, North America and Asia; 2015 revenues totalled EUR 236 million.
Alongside Equistone, the current managment of United Initiators is also investing in the corporate group.
P+P Pöllath + Partners advised Equistone on the legal aspects of the transaction and the management participation program with the following team:
- Dr. Andrea von Drygalski (partner, M&A/private equity, lead)
- Dr. Benedikt Hohaus (partner, management participation)
- Stefan Benz (senior associate, M&A/private equity)
- Dr. Verena Stenzel (associate, M&A/private equity)
- Andrea Beilborn (associate, M&A/private equity)
- Dr. Julian Winkler (associate, management participation)
- Michael Wichert (senior associate, real estate)
- Corinna Czermak (associate, M&A/private equity)
P+P Pöllath + Partners regularly advises Equistone on transactions, recently on the sale of Sunrise Medical group, the IN tIME group and the CU CHEMIE UETIKON group.
P+P Pöllath + Partners was lead counsel, supported by AssmannPeiffer Attorneys (Max Peiffer and Lukas Assmann) on energy law. The responsible firm in the U.S. was Thompson Hine and in China, the firm Zhong Lun.
